Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 9, 2005, Pages 1383-1387

  Ohe, Monique N ^a,b   Santos, R O ^a   Barros, E R ^a   Lage, A ^a   Kunii, I S ^a   Abrahao M ^a   Cervantes, O ^a   Hauache, O M ^a   Lazaretti Castro, M ^a   Vieira, J G H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Asymptomatic primary hyperparathyroidism; Clinical presentation; Hypercalcemia; Hyperparathyroidism; Parathyroid hormone; Primary hyperparathyroidism

Indexed keywords

CALCIUM; CALCIUM ION; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AWARENESS; BRAZIL; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERPARATHYROIDISM; QUANTITATIVE ANALYSIS; SCHOOL CHILD; UNIVERSITY HOSPITAL;

EID: 24744445433     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000900013     Document Type: Article

References (18)

1. Popovic JR (2001). 1999 National Hospital Discharge Survey: Annual Summary with Detailed Diagnosis and Procedure Data. DHHS Publication No. (PHS) 2001-1722. U.S. Department of Health and Human Services, Hyattsville, MD, USA.
2. Melton III LJ (2002). The epidemiology of primary hyperparathyroidism in North America. Journal of Bone and Mineral Research, 17 (Suppl 2): N12-N17.
3. Adami S, Marcocci C & Gatti D (2002). Epidemiology of primary hyperparathyroidism in Europe. Journal of Bone and Mineral Research, 17 (Suppl 2): N18-N23.
4. Wynne AG, Van Heerden J, Carney JA et al. (1992). Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine, 71: 197-205.
5. Silverberg SJ, Shane E, Thomas PJ et al. (1999). A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine, 341: 1249-1255.
6. Bilezikian JP (1999). Primary hyperparathyroidism. In: Favus MJ (Editor), Primer on the Metabolic Bone Diseases Disorder of Mineral Metabolism. 4th edn. Chicago, IL, USA, 187-192.
7. Hauache OM, Amarante ECJ, Mendoza B et al. (1995). Análise clínica, laboratorial e achados cirúrgicos de 28 casos de hiperparatiroidismo primário. Arquivos Brasileiros de Endocrinologia e Metabologia, 39: 157-162.
8. Vieira JGH, Oliveira MAD, Maciel RMB et al. (1986). Development of a homologous radioimmunoassay for the synthetic amino terminal (1-34) fragment of human parathyroid hormone using egg yolk-obtained antibodies. Journal of Immunoassay, 7: 57-72.
9. Vieira JGH, Nishida SK, Kasamatsu TS et al. (1994). Development of an immunofluorometric assay for intact parathyroid hormone. Brazilian Journal of Medical and Biological Research, 27: 2379-2382.
10. Bilezikian JP, Meng X, Shi Y et al. (2000). Primary hyperparathyroidism in women: a tale of two cities: New York and Beijing. International Journal of Fertility and Women's Medicine, 45: 158-165.
11. Biyabani SR & Talati J (1999). Bone and renal stone disease in patients operated for primary hyperparathyroidism in Pakistan: is the pattern of disease different from the west? Journal of the Pakistan Medical Association, 49: 194-198.
12. Morimitsu LK, Uyeno MNO, Goulart ML et al. (2001). Carcinoma de paratiróide: características clínicas e anátomo-patológicas de cinco casos. Arquivos Brasileiros de Endocrinologia e Metabologia, 45: 148-156.
13. Silverberg SJ & Bilezikian JP (2003). "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. Journal of Clinical Endocrinology and Metabolism, 88: 5348-5352.
14. Souberbielle JC, Cormier C, Kindermans C et al. (2001). Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Journal of Clinical Endocrinology and Metabolism, 86: 3086-3090.
15. Silverberg SJ, Shane E, Dempster DW et al. (1999). The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. American Journal of Medicine, 107: 561-567.
16. Kantorovich V, Gacad MA, Seeger LL et al. (2000). Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 85: 3541-3543.
17. Harinarayan DV, Gupta N & Kochupillai N (1995). Vitamin D status in primary hyperparathyroidism in India. Clinical Endocrinology, 43: 351-358.
18. Rao DS, Honasoge M, Divine GW et al. (2000). Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. Journal of Clinical Endocrinology and Metabolism, 85: 1054-1058.